Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002886258 | SCV003245958 | uncertain significance | Hepatic veno-occlusive disease-immunodeficiency syndrome | 2022-08-21 | criteria provided, single submitter | clinical testing | This sequence change affects codon 223 of the SP110 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the SP110 protein. This variant is present in population databases (rs376677600, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SP110-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003926463 | SCV004751848 | likely benign | SP110-related disorder | 2019-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |